Viewing Identification Module

Viewing Identification Module

A * next to a definition means that it is a required value within a study.

The Database Structure: Study => Sections => Modules. You are currently viewing an Identification Module Field Definitions List within a Protocol Section.

NCTid *: The NCTid is the National Clinical Trial Identifier Number. It is assigned by the National Library of Medicine (NLM) at http://clinicaltrials.gov/ website when a new study appears in the NLM Clinical Trials data base. The format is like this: NCT0630xxxx. All Studies have an NCT ID, the entire system uses this as a unique identifier.

NCTid Alias List: A List of NCT's Related to this Study.

Org Study ID Info: The information is submitted by the Organization.

Brief Title *: A short title of the clinical study written in language intended for the lay public. The title should include, where possible, information on the participants, condition being evaluated, and intervention(s) studied. Limit: 300 characters.

Official Title *: The title of the clinical study, corresponding to the title of the protocol. Limit: 600 characters.

Acronym: An acronym or abbreviation used publicly to identify the clinical study, if any. Limit: 14 characters.

Secondary IDs: An identifier(s) (ID), if any, other than the organization's Unique Protocol Identification Number or the NCT number that is assigned to the clinical study. This includes any unique clinical study identifiers assigned by other publicly available clinical trial registries. If the clinical study is funded in whole or in part by a U.S. Federal Government agency, the complete grant or contract number must be submitted as a Secondary ID. Limit: 30 characters. If there is a Secondary ID, then the following information must be provided:

Secondary ID Type [*] Definition: A description of the type of Secondary ID. Select one.

U.S. National Institutes of Health (NIH) Grant/Contract Award Number: In the Secondary ID field, include activity code, institute code, and 6-digit serial number. Other components of the full award number (type code, support year, and suffix) are optional.

Other Grant/Funding Number: Identifier assigned by a funding organization other than the U.S. NIH; also required to enter the name of the funding organization.

Registry Identifier: Number assigned by a clinical trial registry (for example, a registry that is part of the World Health Organization [WHO] Registry Network); also required to enter the name of the clinical trial registry.

EudraCT Number: Identifier assigned by the European Medicines Agency Clinical Trials Database (EudraCT).

Other Identifier: Also required to enter a brief description of the identifier (for example, the name of organization that issued the identifier).

Description [*] Definition: If a Secondary ID Type of "Other Grant/Funding Number," "Registry Identifier," or "Other Identifier" is selected, provide the name of the funding organization, clinical trial registry, or organization that issued the identifier. Limited: 119 characters.

Viewing Identification Module


Ignite Creation Date: 2024-05-06 @ 7:58 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Protocol Section: NCT06200467
NCT ID *: NCT06200467
NCTid Alias List:
Org Study Id: 1404-0011
Org Study Id Type: None
Org Study Domain: None
Org Study Id Link: None
Organization:
Organization Class: INDUSTRY
Brief Title *: A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
Official Title: A Double-blind Randomized Placebo-controlled Multiple-dose Parallel Group With Nested Crossover Design Trial With Moxifloxacin as Positive Control to Evaluate the Effects of Multiple Subcutaneous Doses of BI 456906 in a Titration Scheme on Cardiac Safety Parameters in Otherwise Healthy Male and Female Subjects With OverweightObesity
Acronym: None
Secondary ID Info:
Secondary IDs
Secondary ID Type Domain Link
U1111-1295-4369 OTHER WHO Registry None
2023-506375-10-00 REGISTRY None None